Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Caitlin E. Cox

May 01, 2025

News Daily News

Having Twins Ups the Risk of CVD Over the Next Year

Caitlin E. Cox

February 06, 2025

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Caitlin E. Cox

June 13, 2023

News Daily News

CVD Risks After Pregnancy Linked to Prenatal Depression

L.A. McKeown

April 21, 2023

News Daily News

Gay Men, Bisexual Women Face Unique Hypertension Risks

Caitlin E. Cox

January 03, 2023

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients

Caitlin E. Cox

August 22, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

News Daily News

Complicated Pregnancies and CVD Risk: Cardiologists Can Be Part of Solution

Caitlin E. Cox

March 30, 2021

Advertisement

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Having Twins Ups the Risk of CVD Over the Next Year

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

CVD Risks After Pregnancy Linked to Prenatal Depression

Gay Men, Bisexual Women Face Unique Hypertension Risks

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Complicated Pregnancies and CVD Risk: Cardiologists Can Be Part of Solution

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content